Latest Breaking News On - Pharma limited nasdaq - Page 3 : comparemela.com

OKYO Pharma Limited Regains Compliance with Nasdaq Listing Minimum Market Value Rule

OKYO Pharma Limited Regains Compliance with Nasdaq Listing Minimum Market Value Rule
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

London
City-of
United-kingdom
Garys-jacob
Paul-spencer
Pharma-limited-nasdaq
Listing-qualifications-department
Nasdaq-stock-market
Nasdaq-capital-market
Nasdaq-listing-rule
Chief-executive
Aktien-sie

OKYO Pharma Limited Announces Withdrawal of Public Offering

OKYO Pharma Limited Announces Withdrawal of Public Offering
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

London
City-of
United-kingdom
Gary-jacob
Paul-spencer
Garys-jacob
Pharma-limited-nasdaq
Chief-executive
Aktien-sie

OKYO Pharma Limited Receives Nasdaq Deficiency Notice

OKYO Pharma Limited Receives Nasdaq Deficiency Notice
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Paul-spencer
Garys-jacob
Nasdaq-listing-qualifications-panel-the
Nasdaq
Pharma-limited-nasdaq
Listing-qualifications-department
Nasdaq-stock-market
Nasdaq-capital-market
Nasdaq-listing-rule
Nasdaq-capital
Market-value
Compliance-date

OKYO Pharma Announces Proposed Public Offering of Ordinary Shares

OKYO Pharma Announces Proposed Public Offering of Ordinary Shares
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
London
City-of
United-kingdom
Garys-jacob
Paul-spencer
Pharma-limited-nasdaq
Exchange-commission
Chief-executive

OKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in Neuropathic Corneal Pain (NCP) Following Announcement of Clinical Trial Agreement with Tufts Medical Center

OKYO Pharma Plans to Initiate Phase 2 Trial of OK-101 in Neuropathic Corneal Pain (NCP) Following Announcement of Clinical Trial Agreement with Tufts Medical Center
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

London
City-of
United-kingdom
Paul-spencer
Garys-jacob
Pedram-hamrah
Tufts-medical-center
Translational-ocular-immunology-at-tufts-medical-center
Cornea-service
Pharma-limited-nasdaq
Principal-investigator
Investigational-new-drug